|
TLK2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.440900E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.650200E-02 |
| Normal-vs-Stage2 |
1.325860E-02 |
| Normal-vs-Stage3 |
1.54439999999756E-06 |
| Normal-vs-Stage4 |
5.233000E-04 |
| Stage1-vs-Stage2 |
1.475450E-01 |
| Stage1-vs-Stage3 |
1.242490E-04 |
| Stage1-vs-Stage4 |
1.812320E-02 |
| Stage2-vs-Stage3 |
2.093600E-01 |
| Stage2-vs-Stage4 |
6.467000E-01 |
| Stage3-vs-Stage4 |
3.836400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.238400E-04 |
| Normal-vs-AfricanAmerican |
1.225970E-02 |
| Normal-vs-Asian |
3.638400E-01 |
| Caucasian-vs-AfricanAmerican |
9.892600E-01 |
| Caucasian-vs-Asian |
5.674300E-02 |
| AfricanAmerican-vs-Asian |
6.125800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.20909999999864E-05 |
| Normal-vs-Female |
5.714100E-02 |
| Male-vs-Female |
1.918400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.556800E-03 |
| Normal-vs-Age(41-60Yrs) |
4.735800E-03 |
| Normal-vs-Age(61-80Yrs) |
1.621850E-03 |
| Normal-vs-Age(81-100Yrs) |
8.224500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.546200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.087200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.906600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.858800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.903600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.135000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.315420E-01 |
| Normal-vs-Grade 2 |
1.168210E-01 |
| Normal-vs-Grade 3 |
1.63019999999126E-06 |
| Normal-vs-Grade 4 |
9.68449999999565E-05 |
| Grade 1-vs-Grade 2 |
5.051900E-02 |
| Grade 1-vs-Grade 3 |
1.562760E-04 |
| Grade 1-vs-Grade 4 |
9.798500E-04 |
| Grade 2-vs-Grade 3 |
4.34329999999816E-05 |
| Grade 2-vs-Grade 4 |
1.875570E-03 |
| Grade 3-vs-Grade 4 |
6.819000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.881600E-01 |
| Normal-vs-ccB subtype |
2.15559999999781E-05 |
| ccA subtype-vs-ccB subtype |
2.0940999999941E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.421800E-03 |
| Normal-vs-N1 |
2.511000E-01 |
| N0-vs-N1 |
9.954000E-01 |
|
|
